ITBMed Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • ITBMed's estimated annual revenue is currently $13.1M per year.(i)
  • ITBMed's estimated revenue per employee is $201,000

Employee Data

  • ITBMed has 65 Employees.(i)
  • ITBMed grew their employee count by 30% last year.

ITBMed's People

NameTitleEmail/Phone
1
Chief Legal and Compliance OfficerReveal Email/Phone
2
VP, Head Regulatory Affairs and Quality AssuranceReveal Email/Phone
3
SVP, Global Head Clinical DevelopmentReveal Email/Phone
4
VP Head Quality AssuranceReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Director, Project ManagementReveal Email/Phone
7
Director, Autoimmunity Program & Early Assets Development - Ops & Program ManagementReveal Email/Phone
8
Associate Director, Clinical OperationsReveal Email/Phone
9
Director, Clinical Supply Chain ManagementReveal Email/Phone
10
Global CMC Regulatory Affairs, Associate DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.7M26716%N/AN/A
#2
$53.1M26421%N/AN/A
#3
$69.1M34426%N/AN/A
#4
$22.1M110-10%N/AN/A
#5
$151.8M75511%N/AN/A
#6
$63.9M31813%N/AN/A
#7
$29.9M14913%N/AN/A
#8
$1.7M17-6%$114.3MN/A
#9
$6.8M34-6%N/AN/A
#10
$12.5M62-9%N/AN/A
Add Company

What Is ITBMed?

keywords:N/A

N/A

Total Funding

65

Number of Employees

$13.1M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ITBMed News

2022-04-19 - Biopharma Credit shareholder sells 4% stake

... kidney disease therapy developer ProKidney and the transplantation research company ITB-Med as well as into philanthropic purposes.

2022-04-13 - Biotechnology Firm Onxeo Appoints Dr. Shefali Agarwal as ...

Agarwal is a member of the Board of Directors of three U.S. biotechnology companies, ITB Med (private), Gritstone Bio (NASDAQ: GRTS) and Fate...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.7M652%N/A
#2
$5.9M6516%N/A
#3
$16.3M653%N/A
#4
$12.9M65-23%N/A
#5
$12.9M6535%N/A